Lincoln Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹157.47Cr |
Net Profits | ₹28.04Cr |
Net Profit Margins | 17.81% |
Highlights
Revenue:
Lincoln Pharmaceuticals Ltd’s revenue jumped 12.38% since last year same period to ₹157.47Cr in the Q3 2023-2024. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -4.38% fall in its revenue since last 3-months.
Net Profits:
Lincoln Pharmaceuticals Ltd’s net profit jumped 29.75% since last year same period to ₹28.04Cr in the Q3 2023-2024. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 1.41% jump in its net profits since last 3-months.
Net Profit Margins:
Lincoln Pharmaceuticals Ltd’s net profit margin jumped 15.46% since last year same period to 17.81% in the Q3 2023-2024. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 6.05% jump in its net profit margins since last 3-months.
